Market Research

Live Biotherapeutics Market (Therapeutic Area: Gastrointestinal Disorders, Metabolic Disorders, Dermatological Diseases, and Others (Cancer, Genito-urinary, Mental Health etc.); and Route of Administration: Oral, Rectal, and Others (Topical etc.) - Global

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 141 Pages Transparency Market Research Pvt. Ltd. July, 2024 TNPR19154782
Best Price Guarantee
Price from $5,795
Length 141 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date July, 2024
SKU TNPR19154782

Live Biotherapeutics Market (Therapeutic Area: Gastrointestinal Disorders, Metabolic Disorders, Dermatological Diseases, and Others (Cancer, Genito-urinary, Mental Health etc.); and Route of Administration: Oral, Rectal, and Others (Topical etc.) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034


Live Biotherapeutics Market – Scope of Report

TMR’s report on the global live biotherapeutics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global live biotherapeutics market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global live biotherapeutics market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the live biotherapeutics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global live biotherapeutics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global live biotherapeutics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global live biotherapeutics market.

The report delves into the competitive landscape of the global live biotherapeutics market. Key players operating in the global live biotherapeutics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global live biotherapeutics market profiled in this report.

Key Questions Answered in Global live biotherapeutics Market Report
  • What is the sales/revenue generated by live biotherapeutics across all regions during the forecast period?
  • What are the opportunities in the global live biotherapeutics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Live Biotherapeutics Market – Research Objectives and Research Approach

The comprehensive report on the global live biotherapeutics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global live biotherapeutics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global live biotherapeutics market.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Live Biotherapeutics Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Live Biotherapeutics Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Epidemiology of Clostridium Difficile Infection
5.3. Insights on Trends in the U.S. Burden of Clostridioides Difficile Infection
5.4. Porters' Five Forces Analysis
6. Global Live Biotherapeutics Market Analysis and Forecast, By Therapeutic Area
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Therapeutic Area, 2020-2034
6.3.1. Gastrointestinal Disorders
6.3.2. Metabolic Disorders
6.3.3. Dermatological Diseases
6.3.4. Others
6.4. Market Attractiveness By Therapeutic Area
7. Global Live Biotherapeutics Market Analysis and Forecast, By Route of Administration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Route of Administration, 2020-2034
7.3.1. Oral
7.3.2. Rectal
7.3.3. Others (Topical etc.)
7.4. Market Attractiveness By Route of Administration
8. Global Live Biotherapeutics Market Analysis and Forecast, By Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Distribution Channel, 2020-2034
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.4. Market Attractiveness By Distribution Channel
9. Global Live Biotherapeutics Market Analysis and Forecast, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America Live Biotherapeutics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Therapeutic Area, 2020-2034
10.2.1. Gastrointestinal Disorders
10.2.2. Metabolic Disorders
10.2.3. Dermatological Diseases
10.2.4. Others
10.3. Market Value Forecast By Route of Administration, 2020-2034
10.3.1. Oral
10.3.2. Rectal
10.3.3. Others (Topical etc.)
10.4. Market Value Forecast By Distribution Channel, 2020-2034
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Market Value Forecast By Country, 2020-2034
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Therapeutic Area
10.6.2. By Route of Administration
10.6.3. By Distribution Channel
10.6.4. By Country
11. Europe Live Biotherapeutics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Therapeutic Area, 2030-2034
11.2.1. Gastrointestinal Disorders
11.2.2. Metabolic Disorders
11.2.3. Dermatological Diseases
11.2.4. Others
11.3. Market Value Forecast By Route of Administration, 2030-2034
11.3.1. Oral
11.3.2. Rectal
11.3.3. Others (Topical etc.)
11.4. Market Value Forecast By Distribution Channel, 2030-2034
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Market Value Forecast By Country, 2030-2034
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Therapeutic Area
11.6.2. By Route of Administration
11.6.3. By Distribution Channel
11.6.4. By Country
12. Asia Pacific Live Biotherapeutics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Therapeutic Area, 2031-2034
12.2.1. Gastrointestinal Disorders
12.2.2. Metabolic Disorders
12.2.3. Dermatological Diseases
12.2.4. Others
12.3. Market Value Forecast By Route of Administration, 2031-2034
12.3.1. Oral
12.3.2. Rectal
12.3.3. Others (Topical etc.)
12.4. Market Value Forecast By Distribution Channel, 2031-2034
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Market Value Forecast By Country, 2031-2034
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Therapeutic Area
12.6.2. By Route of Administration
12.6.3. By Distribution Channel
12.6.4. By Country
13. Latin America Live Biotherapeutics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Therapeutic Area, 2032-2034
13.2.1. Gastrointestinal Disorders
13.2.2. Metabolic Disorders
13.2.3. Dermatological Diseases
13.2.4. Others
13.3. Market Value Forecast By Route of Administration, 2032-2034
13.3.1. Oral
13.3.2. Rectal
13.3.3. Others (Topical etc.)
13.4. Market Value Forecast By Distribution Channel, 2032-2034
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Market Value Forecast By Country, 2032-2034
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Therapeutic Area
13.6.2. By Route of Administration
13.6.3. By Distribution Channel
13.6.4. By Country
14. Middle East & Africa Live Biotherapeutics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Therapeutic Area, 2032-2034
14.2.1. Gastrointestinal Disorders
14.2.2. Metabolic Disorders
14.2.3. Dermatological Diseases
14.2.4. Others
14.3. Market Value Forecast By Route of Administration, 2032-2034
14.3.1. Oral
14.3.2. Rectal
14.3.3. Others (Topical etc.)
14.4. Market Value Forecast By Distribution Channel, 2032-2034
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Online Pharmacies
14.5. Market Value Forecast By Country, 2032-2034
14.5.1. GCC
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Therapeutic Area
14.6.2. By Route of Administration
14.6.3. By Distribution Channel
14.6.4. By Country
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2023)
15.3. Company Profiles
15.3.1. Ferring Pharmaceuticals
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Seres Therapeutics
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Rebiotix Inc.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. 4D Pharma
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Finch Therapeutics
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Vedanta Biosciences
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Synthetic Biologics
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. MaaT Pharma
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.9. Enterome
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.10. Second Genome
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings